Drugs / Inactivated Influenza A/H5N1 Vaccine
Inactivated Influenza A/H5N1 Vaccine
also known as
Inactivated monovalent subvirion influenza H5N1 vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00294099 | Mar 2006 → Mar 2007 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Influenza A/H5N1 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00294099 ↗ |
| Known as | Inactivated monovalent subvirion influenza H5N1 vaccine | “Inactivated monovalent subvirion influenza H5N1 vaccine. Supplied in 0.5 mL unit dose vials as a sterile solution for IM injection.” NCT00294099 ↗ |
| Modality | Vaccine | “new A/H5N1 flu vaccine” NCT00294099 ↗ |
| Route | Intramuscular | “by intramuscular injection” NCT00294099 ↗ |